386 related articles for article (PubMed ID: 16193304)
1. Novel diaroylhydrazine ligands as iron chelators: coordination chemistry and biological activity.
Bernhardt PV; Chin P; Sharpe PC; Wang JY; Richardson DR
J Biol Inorg Chem; 2005 Nov; 10(7):761-77. PubMed ID: 16193304
[TBL] [Abstract][Full Text] [Related]
2. Development of novel aroylhydrazone ligands for iron chelation therapy: 2-pyridylcarboxaldehyde isonicotinoyl hydrazone analogs.
Becker E; Richardson DR
J Lab Clin Med; 1999 Nov; 134(5):510-21. PubMed ID: 10560945
[TBL] [Abstract][Full Text] [Related]
3. The potential of iron chelators of the pyridoxal isonicotinoyl hydrazone class as effective antiproliferative agents II: the mechanism of action of ligands derived from salicylaldehyde benzoyl hydrazone and 2-hydroxy-1-naphthylaldehyde benzoyl hydrazone.
Richardson DR; Milnes K
Blood; 1997 Apr; 89(8):3025-38. PubMed ID: 9108424
[TBL] [Abstract][Full Text] [Related]
4. The potential of iron chelators of the pyridoxal isonicotinoyl hydrazone class as effective antiproliferative agents III: the effect of the ligands on molecular targets involved in proliferation.
Darnell G; Richardson DR
Blood; 1999 Jul; 94(2):781-92. PubMed ID: 10397746
[TBL] [Abstract][Full Text] [Related]
5. The effect of the iron(III) chelator, desferrioxamine, on iron and transferrin uptake by the human malignant melanoma cell.
Richardson D; Ponka P; Baker E
Cancer Res; 1994 Feb; 54(3):685-9. PubMed ID: 8306330
[TBL] [Abstract][Full Text] [Related]
6. Heterocyclic dithiocarbazate iron chelators: Fe coordination chemistry and biological activity.
Basha MT; Chartres JD; Pantarat N; Ali MA; Mirza AH; Kalinowski DS; Richardson DR; Bernhardt PV
Dalton Trans; 2012 Jun; 41(21):6536-48. PubMed ID: 22362375
[TBL] [Abstract][Full Text] [Related]
7. The potential of iron chelators of the pyridoxal isonicotinoyl hydrazone class as effective antiproliferative agents.
Richardson DR; Tran EH; Ponka P
Blood; 1995 Dec; 86(11):4295-306. PubMed ID: 7492790
[TBL] [Abstract][Full Text] [Related]
8. Unprecedented oxidation of a biologically active aroylhydrazone chelator catalysed by iron(III): serendipitous identification of diacylhydrazine ligands with high iron chelation efficacy.
Bernhardt PV; Chin P; Richardson DR
J Biol Inorg Chem; 2001 Oct; 6(8):801-9. PubMed ID: 11713687
[TBL] [Abstract][Full Text] [Related]
9. The iron metabolism of the human neuroblastoma cell: lack of relationship between the efficacy of iron chelation and the inhibition of DNA synthesis.
Richardson DR; Ponka P
J Lab Clin Med; 1994 Nov; 124(5):660-71. PubMed ID: 7964124
[TBL] [Abstract][Full Text] [Related]
10. Tuning the antiproliferative activity of biologically active iron chelators: characterization of the coordination chemistry and biological efficacy of 2-acetylpyridine and 2-benzoylpyridine hydrazone ligands.
Bernhardt PV; Wilson GJ; Sharpe PC; Kalinowski DS; Richardson DR
J Biol Inorg Chem; 2008 Jan; 13(1):107-19. PubMed ID: 17899222
[TBL] [Abstract][Full Text] [Related]
11. Examination of the antiproliferative activity of iron chelators: multiple cellular targets and the different mechanism of action of triapine compared with desferrioxamine and the potent pyridoxal isonicotinoyl hydrazone analogue 311.
Chaston TB; Lovejoy DB; Watts RN; Richardson DR
Clin Cancer Res; 2003 Jan; 9(1):402-14. PubMed ID: 12538494
[TBL] [Abstract][Full Text] [Related]
12. Mobilization of iron from neoplastic cells by some iron chelators is an energy-dependent process.
Richardson DR
Biochim Biophys Acta; 1997 May; 1320(1):45-57. PubMed ID: 9186779
[TBL] [Abstract][Full Text] [Related]
13. Iron catalysed assembly of an asymmetric mixed-ligand triple helicate.
Bernhardt PV; Chin P; Richardson DR
Dalton Trans; 2004 Oct; (20):3342-6. PubMed ID: 15483720
[TBL] [Abstract][Full Text] [Related]
14. Mobilization of intracellular iron by analogs of pyridoxal isonicotinoyl hydrazone (PIH) is determined by the membrane permeability of the iron-chelator complexes.
Buss JL; Arduini E; Ponka P
Biochem Pharmacol; 2002 Dec; 64(12):1689-701. PubMed ID: 12445858
[TBL] [Abstract][Full Text] [Related]
15. Structure-activity relationships of novel iron chelators for the treatment of iron overload disease: the methyl pyrazinylketone isonicotinoyl hydrazone series.
Kalinowski DS; Sharpe PC; Bernhardt PV; Richardson DR
J Med Chem; 2008 Jan; 51(2):331-44. PubMed ID: 18159922
[TBL] [Abstract][Full Text] [Related]
16. Protection against hydrogen peroxide-mediated cytotoxicity in Friedreich's ataxia fibroblasts using novel iron chelators of the 2-pyridylcarboxaldehyde isonicotinoyl hydrazone class.
Lim CK; Kalinowski DS; Richardson DR
Mol Pharmacol; 2008 Jul; 74(1):225-35. PubMed ID: 18424550
[TBL] [Abstract][Full Text] [Related]
17. A turn-on fluorescent iron complex and its cellular uptake.
Chartres JD; Busby M; Riley MJ; Davis JJ; Bernhardt PV
Inorg Chem; 2011 Sep; 50(18):9178-83. PubMed ID: 21812394
[TBL] [Abstract][Full Text] [Related]
18. Hydrazone chelators for the treatment of iron overload disorders: iron coordination chemistry and biological activity.
Bernhardt PV; Chin P; Sharpe PC; Richardson DR
Dalton Trans; 2007 Aug; (30):3232-44. PubMed ID: 17893768
[TBL] [Abstract][Full Text] [Related]
19. Cytotoxic iron chelators: characterization of the structure, solution chemistry and redox activity of ligands and iron complexes of the di-2-pyridyl ketone isonicotinoyl hydrazone (HPKIH) analogues.
Bernhardt PV; Caldwell LM; Chaston TB; Chin P; Richardson DR
J Biol Inorg Chem; 2003 Nov; 8(8):866-80. PubMed ID: 14564555
[TBL] [Abstract][Full Text] [Related]
20. Conjugates of desferrioxamine B (DFOB) with derivatives of adamantane or with orally available chelators as potential agents for treating iron overload.
Liu J; Obando D; Schipanski LG; Groebler LK; Witting PK; Kalinowski DS; Richardson DR; Codd R
J Med Chem; 2010 Feb; 53(3):1370-82. PubMed ID: 20041672
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
